Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Molecular Therapy. Nucleic Acids|August 18, 2020
MYC ASO Impedes Tumorigenesis and Elicits Oncogene Addiction in Autochthonous Transgenic Mouse Models of HCC and RCCRenumathy Dhanasekaran, Jangho Park, Alekesey Yevtodiyenko, et al.Plos One|May 8, 2008
Combined Inactivation of MYC and K-Ras oncogenes reverses tumorigenesis in lung adenocarcinomas and lymphomasPhuoc T Tran, Alice C Fan, Pavan K Bendapudi, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|October 22, 2009
Low-level shRNA cytotoxicity can contribute to MYC-induced hepatocellular carcinoma in adult miceShelly Beer, David I Bellovin, Joyce S Lee, et al.Cancer Research Communications|September 4, 2023
Discovery and Characterization of ZL-2201, a Potent, Highly Selective, and Orally Bioavailable Small-molecule DNA-PK InhibitorShruti Lal, Neil E Bhola, Bee-Chun Sun, et al.Proceedings of the National Academy of Sciences of the United States of America|May 13, 2015
MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolismEmelyn H Shroff, Livia S Eberlin, Vanessa M Dang, et al.Elife|January 15, 2020
MYC and Twist1 cooperate to drive metastasis by eliciting crosstalk between cancer and innate immunityRenumathy Dhanasekaran, Virginie Baylot, Minsoon Kim, et al.Investigational New Drugs|May 9, 2019
A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesotheliomaEmilie M J van Brummelen, Evgeny Levchenko, Manuel Dómine, et al.Cell Metabolism|September 22, 2015
MYC Disrupts the Circadian Clock and Metabolism in Cancer CellsBrian J Altman, Annie L Hsieh, Arjun Sengupta, et al.Pageof 2